News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • European natural gas prices rose after intensifying Israeli airstrikes in Lebanon, prompting a risk repricing in energy markets.
  • BMW will open talks with employee representatives after cutting its profit outlook.
  • Acting Director of National Intelligence initiated a personnel review that could cut hundreds of ODNI jobs.
  • Evonik shares jumped after Deutsche Bank raised its price target and forecast a Q2 earnings beat.
  • uniQure reported preliminary Phase I/IIa data showing AMT-260 was well tolerated and halved seizures in three of six patients.
  • Berenberg initiated coverage of Meridian Mining with a buy rating, modeling the Cabaçal project to start production in late 2028.

Latest Articles

Why Microsoft Is an Underappreciated AI Compounder — Buy the Setup

Why Microsoft Is an Underappreciated AI Compounder — Buy the Setup

Microsoft's scale, cloud footprint, and high-margin software flywheel position it to compound earnings meaningfully as AI monetization accelerates. The market is pricing growth conservatively — we initiate a long trade at $400.00 with a $480 target and $360 stop over a 180-trading-day horizon, balancing upside from multiple catalysts against execut…

Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

Outlook Therapeutics Announces FDA Acceptance of Resubmitted Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) as a Treatment for Wet AMD

Outlook Therapeutics announced that the FDA has accepted the resubmitted Biologics License Application for their ophthalmic formulation of bevacizumab, ONS-5010/LYTENAVA™, intended to treat wet age-related macular degeneration (AMD). This marks a significant regulatory milestone with a PDUFA action date set for July 29, 2026. The drug is already au…

Edwards Lifesciences Rallies After U.S. Proposal Expands TAVR Coverage

Edwards Lifesciences Rallies After U.S. Proposal Expands TAVR Coverage

Edwards Lifesciences shares climbed 3.6% on Tuesday after the U.S. government published a proposed National Coverage Decision that would broaden coverage for transcatheter aortic-valve replacement (TAVR). Key changes in the memo include coverage for asymptomatic severe aortic stenosis under coverage with evidence development, removal of the dual-op…

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk

BioAge Labs Announces First Participant Dosed in QUELL-CV, a Phase 2 Proof-of-Concept Trial of BGE-102, a Novel Oral NLRP3 Inhibitor, in Patients at Elevated Cardiovascular Risk

BioAge Labs has dosed the first participant in the Phase 2 QUELL-CV trial evaluating BGE-102, a novel oral NLRP3 inhibitor aimed at reducing cardiovascular risk driven by inflammation. The randomized, placebo-controlled study will assess dose-ranging efficacy and safety in adults with elevated systemic inflammation and cardiovascular risk factors, …

BigCommerce Earns 2026 Top Rated Award From TrustRadius

BigCommerce Earns 2026 Top Rated Award From TrustRadius

Commerce.com, Inc., parent company of BigCommerce, announced that BigCommerce has received the 2026 Top Rated Award from TrustRadius, reflecting high customer satisfaction with its ecommerce platform. The award is based solely on verified customer reviews praising its features such as multi-brand storefront management, robust catalog handling, and …

EquipmentShare Assigned First-Time ‘BB-’ Issuer Default Rating by Fitch; Senior Secured Second Lien Notes Rated ‘BB’; Outlook Stable

EquipmentShare Assigned First-Time ‘BB-’ Issuer Default Rating by Fitch; Senior Secured Second Lien Notes Rated ‘BB’; Outlook Stable

EquipmentShare.com Inc, a leading US construction equipment rental and technology provider, received its first Fitch Long-Term Issuer Default Rating of 'BB-' with a Stable outlook. Fitch also assigned ratings of 'BB+' and 'BB' to EquipmentShare's asset-based lending revolving credit facility and senior secured second lien notes, respectively. The r…

Sanuwave Health Updates Second Quarter 2026 Guidance

Sanuwave Health Updates Second Quarter 2026 Guidance

Sanuwave Health, Inc. revised its second-quarter 2026 revenue guidance downward to $8.5-$9.5 million due to market disruptions affecting sales of its Ultramist directed energy system. Despite robust unit sales of applicators, challenges such as widespread CMS reimbursement clawbacks and the emergence of a secondary market for used Ultramist systems…

Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study

Calidi Biotherapeutics announced positive pre-IND feedback from the US FDA regarding its lead candidate CLD-401, an oncolytic virus designed to deliver IL-15 superagonist genetically to treat solid tumors. The FDA's agreement on preclinical and clinical strategies paves the way for Calidi to submit its IND by year-end 2026 and initiate Phase 1 clin…

VisionWave Holdings Signs Term Sheet for a Proposed Tier IV Data Center Joint Venture with Lucky Whale Production Limited

VisionWave Holdings Signs Term Sheet for a Proposed Tier IV Data Center Joint Venture with Lucky Whale Production Limited

VisionWave Holdings, Inc. announced a term sheet with Lucky Whale Production Limited to jointly develop, own, and operate a Tier IV data center campus in Beth Shemesh, Israel. VisionWave would hold a 68% stake in the joint company, representing an effective 51% interest in the project, with the consideration being mostly equity issuance worth appro…

Skyline Builders Group Holding Limited to Change Ticker Symbol to “KAZR” Ahead of Expected Combination with Cove Kaz

Skyline Builders Group Holding Limited to Change Ticker Symbol to “KAZR” Ahead of Expected Combination with Cove Kaz

Skyline Builders Group Holding Limited (Nasdaq: SKBL) will change its ticker symbol to KAZR in anticipation of a pending business combination with Cove Kaz Capital Group LLC, a U.S.-backed critical minerals developer in Kazakhstan. The merger aims to create Kaz Resources Inc., a strategic supplier of critical minerals focused on serving U.S. custom…

SailPoint Launches Unified Platform Access to Fuel Partner Innovation

SailPoint Launches Unified Platform Access to Fuel Partner Innovation

SailPoint, Inc., a leader in enterprise identity security, launched Unified Platform Access, an enhancement to its Technology Alliance Partners Program. This initiative provides partners with seamless, direct access to the SailPoint platform to build native, automated applications, fostering innovation and stronger integration across the identity s…

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Picard Medical, parent company of SynCardia Systems, is presenting advanced in vivo data on its next-generation Emperor Total Artificial Heart, along with new clinical outcome research from their established SynCardia Total Artificial Heart, at the ASAIO 2026 conference. These presentations highlight technological advancements and real-world patien…

TEGNA CEO Patrick Paolini Appoints Kurt Rao Executive Vice President and Chief Technology and Digital Products Officer

TEGNA CEO Patrick Paolini Appoints Kurt Rao Executive Vice President and Chief Technology and Digital Products Officer

TEGNA Inc. has appointed Kurt Rao to the newly created role of executive vice president and chief technology and digital products officer. Rao will lead the strategy and execution of TEGNA's digital products and technology platforms, integrating product management, technology, engineering, and operations to enhance local news delivery across multip…

Breckenridge Distillery Celebrates America's 250th Anniversary with the Launch of Patriotic Reserve Bourbon Whiskey

Breckenridge Distillery Celebrates America's 250th Anniversary with the Launch of Patriotic Reserve Bourbon Whiskey

Tilray Brands' Breckenridge Distillery introduced Patriotic Reserve Bourbon Whiskey, a limited-edition blend honoring America's spirit ahead of the 250th Independence Day anniversary. The bourbon blends straight bourbons with American-sourced grains and Rocky Mountain water, emphasizing resilience and pride. It is available nationally and online, p…

Vera Bradley Debuts at Nordstrom Stores Nationwide and Nordstrom.com

Vera Bradley Debuts at Nordstrom Stores Nationwide and Nordstrom.com

Vera Bradley, Inc. (NASDAQ: VRA) has announced its debut at Nordstrom stores nationwide and on Nordstrom.com, marking its first-ever partnership with the major fashion retailer. The curated assortment includes a mix of new and relaunched highly popular products, aiming to expand brand reach, especially among Gen Z and millennial consumers. The init…

authID and Trinsic Partner to Deliver Secure and Easily Deployable Biometric-Powered Digital Identity

authID and Trinsic Partner to Deliver Secure and Easily Deployable Biometric-Powered Digital Identity

authID has partnered with Trinsic to integrate Digital ID support into its Proof™ biometric identity platform. This collaboration enables organizations to verify users globally using trusted digital IDs combined with biometric authentication, enhancing security and privacy while simplifying compliance. The partnership significantly expands authID's…

Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301

Cingulate Inc. announced the issuance of its first wholly owned U.S. patent for its lead ADHD asset, CTx-1301, covering its proprietary Precision Timed Release™ technology. The patent strengthens Cingulate's intellectual property portfolio and supports its progress toward potential commercialization of the once-daily ADHD treatment. The company foc…